- Home
- LESL vs LUNG Comparison
LESL vs LUNG Comparison
Compare LESL & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LESL
- LUNG
- Stock Information
- Founded
- LESL 1963
- LUNG 1995
- Country
- LESL United States
- LUNG United States
- Employees
- LESL N/A
- LUNG N/A
- Industry
- LESL Diversified Commercial Services
- LUNG Industrial Specialties
- Sector
- LESL Miscellaneous
- LUNG Health Care
- Exchange
- LESL Nasdaq
- LUNG Nasdaq
- Market Cap
- LESL 66.9M
- LUNG 65.6M
- IPO Year
- LESL 2020
- LUNG 2020
- Fundamental
- Price
- LESL $0.33
- LUNG $1.71
- Analyst Decision
- LESL Hold
- LUNG Buy
- Analyst Count
- LESL 9
- LUNG 7
- Target Price
- LESL $1.66
- LUNG $7.66
- AVG Volume (30 Days)
- LESL 3.0M
- LUNG 856.3K
- Earning Date
- LESL 08-06-2025
- LUNG 10-29-2025
- Dividend Yield
- LESL N/A
- LUNG N/A
- EPS Growth
- LESL N/A
- LUNG N/A
- EPS
- LESL N/A
- LUNG N/A
- Revenue
- LESL $1,250,568,000.00
- LUNG $90,549,000.00
- Revenue This Year
- LESL N/A
- LUNG $10.30
- Revenue Next Year
- LESL $1.27
- LUNG $14.72
- P/E Ratio
- LESL N/A
- LUNG N/A
- Revenue Growth
- LESL N/A
- LUNG 18.24
- 52 Week Low
- LESL $0.27
- LUNG $1.47
- 52 Week High
- LESL $3.63
- LUNG $9.37
- Technical
- Relative Strength Index (RSI)
- LESL 44.33
- LUNG 41.25
- Support Level
- LESL $0.29
- LUNG $1.62
- Resistance Level
- LESL $0.36
- LUNG $1.89
- Average True Range (ATR)
- LESL 0.04
- LUNG 0.12
- MACD
- LESL 0.01
- LUNG 0.07
- Stochastic Oscillator
- LESL 62.02
- LUNG 57.14
About LESL Leslie's Inc.
Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products across chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company offers its products and services for Residential Pool, Residential Spa, Professional Pool, and Commercial Pool consumers. Geographically, it operates only in the United States.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.